1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About Invacare Corp.

Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the Company designs, manufactures, and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The Company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The Company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The Company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, distributors and government health services in North America, Europe and Asia Pacific.
Matthew Monaghan

PO Box 4028
1 Invacare Way
Elyria, Ohio 44036-2028
Phone: 14403296000


Invacare Corporation – Consensus Indicates Potential 359.1% Upside
Aug 11, 2022 10:08am

Invacare Corporation with ticker code (IVC) have now 3 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 6 and 1.3 and has a mean target at 4.27. Given that the stocks previous close was at 0.93 this now indicates there is a potential upside of 359.1%. The day 50 moving average is 1.26 and the 200 day moving average is 2.06. The market capitalisation for the company is $38m. You can visit the company''s website by visiting: https://www.invacare.com [stock_market_widget type="chart" template="basic" color="green" assets="IVC" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $173m based on the market concensus. Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products under the Invacare brand, as well as custom molded seat modules under the PinDot brand.

Invacare Corporation''s (IVC) CEO Matt Monaghan on Q2 2022 Results - Earnings Call Transcript
Aug 09, 2022 14:25pm

Invacare Corporation (NYSE:NYSE:IVC) Q2 2022 Earnings Conference Call August 9, 2022 8:30 A.M.

Source:Seeking Alpha
Recap: Invacare Q2 Earnings
Aug 08, 2022 21:15pm

Invacare (NYSE: IVC ) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM. Here''s what investors need to know about the announcement. Earnings Invacare missed estimated earnings by 47.62%, reporting an EPS of $-0.62 versus an … Full story available on Benzinga.com

Invacare Q2 GAAP loss per share widens Y/Y, revenue $189M down, FY22 guidance suspended
Aug 08, 2022 21:05pm

Invacare press release (IVC): Q2 GAAP EPS of -$0.62 (vs

Source:Seeking Alpha
Invacare Corp Q2 Loss Rises
Aug 08, 2022 20:52pm

WASHINGTON (dpa-AFX) - Invacare Corp (IVC) released Loss for its second quarter that increased from last yearThe company''s bottom line came in at -$21.94 million, or -$0.62 per share. This compare…

Source:Finanz Nachrichten
Invacare Reports Results for Second Quarter 2022
Aug 08, 2022 20:20pm

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) ("Invacare" or the "company") today reported results for the quarter ended June 30, 2022. Executive Summary Reflecting on the quarter, Matt Monaghan, chairman, president, and chief executive officer, said "In 2Q22, we achieved sequential revenue growth of 4.7% in mobility & seating products driven by increased adoption of our compelling product portfolio. We continue to experience elevated backlog across all product categories

Source:Business Wire
FedEx purchasing $200M of Berkshire Grey robots
Aug 03, 2022 00:00am

FedEx continues to embrace automation to streamline operations and drive long-term efficiencies.

First Trulieve-Branded Dispensary Opens in Arizona
Aug 03, 2022 00:00am

Trulieve Cannabis Corp. announced the opening of its first Trulieve-branded dispensary in Arizona, located at 1007 N. 7th St. The doors opened at 8 a.m. on Tuesday, Aug. 2, with ongoing hours of 8 a.m. – 10 p.m., seven days a week. This is the first cannabis dispensary in the Roosevelt Row neighborhood in downtown…

Invacare Corporation to Host Conference Call and Webcast to Discuss Second Quarter 2022 Financial Results
Jul 20, 2022 12:00pm

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) (“Invacare” or the “company”) announces that it will release its financial results for the second quarter ended June 30, 2022, after the market closes on Monday, August 8, 2022. The company will provide a live conference call and webcast to discuss these financial results on Tuesday, August 9, 2022, at 8:30 AM ET. Investors and other interested parties may access the webcast and conference call in the following ways: Those wishing

Source:Business Wire
Upper Body Ergometers Market Size Trends Growth Value Forecast to 2032 | Invacare Corporation, Medline Industries, Inc., Dynatronics Corporation
Jul 18, 2022 14:34pm

Global Upper Body Ergometers industry document provides actionable industry insights with which sustainable, valuable, and money-spinning business strategies can be created. Here, industry segmentation is carried out in detail based on various parameters that include applications, end use industries, deployment model, and

Invacare Corporation (IVC): Why Is The Stock Strong?
Jun 27, 2022 14:30pm

Invacare Corporation (NYSE:IVC) has a beta value of 0.41 and has seen 4.25 million shares traded in the last trading session. The company, currently valued at $53.10M, closed the last trade at $1.46 per share which meant it lost -$0.03 on the day or -2.01% during that session. The IVC stock price is -504.79% off … Invacare Corporation (IVC): Why Is The Stock Strong? Read More »

Source:Marketing Sentinel